P.05.9 RISK ANALYSIS OF PNEUMONIA IN TWO DIFFERENT COHORTS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES

dipropionate in inducing remission and improving quality of life in patients with chronic refractory pouchitis. Material and methods: Ten consecutive patients with active pouchitis, not responding after 1 month of antibiotic treatment were treated with beclomethasone dipropionate 10 mg/day for 8 weeks. Symptomatic, endoscopic and histological evaluations were undertaken before and after treatment according to Pouchitis Disease Activity Index. Remission was defined as a combination of Pouchitis Disease Activity Index clinical score of =2, endoscopic score of =1 and total Pouchitis Disease Activity Index score of =4. Results: Eigth of 10 patients (80%) achieved remission. The median total Pouchitis Disease Activity Index scores before and after therapy were, respectively, 12 (range 8–14) and 3 (range 2–9) (P